Tenax Therapeutics (TENX) Operating Margin (2011 - 2015)

Tenax Therapeutics (TENX) reported Operating Margin of 9874.97% for Q2 2015, down 951.85% sequentially from 938.82% in Q2 2013.

Tenax Therapeutics (TENX) Operating Margin (2011 - 2015) Analysis & Trends

Tenax Therapeutics (TENX) has 4 years of Operating Margin data on file, last reported at 9874.97% in Q2 2015.

For the quarter ending Q2 2015, Operating Margin changed N/A year-over-year to 9874.97%; the trailing twelve-month figure through Jun 2016 stood at 29548.27% (down 2863046.0% YoY), and the FY2015 full-year result was 33603.73%, changed N/A from the prior year.
Operating Margin declined to 9874.97% in Q2 2015, from 938.82% in the prior quarter.
In the past five years, Operating Margin ranged from a high of 6152.14% in Q2 2011 to a low of 9874.97% in Q2 2015.
A 4-year average of 2298.55% and a median of 1110.67% in 2013 frame the typical range for Operating Margin.
Peak annual rise in Operating Margin reached 913333 bps in 2012, while the deepest fall reached 810436 bps in 2012.
Tracing TENX's Operating Margin over 4 years: stood at 3848.96% in 2011, then jumped by 97 bps to 134.04% in 2012, then tumbled by 600 bps to 938.82% in 2013, then sank by 952 bps to 9874.97% in 2015.
Business Quant data shows TENX's Operating Margin at 9874.97% in Q2 2015, 938.82% in Q2 2013, and 715.64% in Q1 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Operating Margin (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	16.51%
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	38.10%
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	17.83%
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	30.35%
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Tenax Therapeutics	655.78 Mn	655.78 Mn	-	-

Download Data